These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36854070)

  • 1. Diagnostic and Treatment Strategies for AL Amyloidosis in an Era of Therapeutic Innovation.
    Dima D; Mazzoni S; Anwer F; Khouri J; Samaras C; Valent J; Williams L
    JCO Oncol Pract; 2023 May; 19(5):265-275. PubMed ID: 36854070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [To positively deal with the challenges brought by the diagnosis and treatment of systemic light chain amyloidosis].
    Huang XH; Liu ZH
    Zhonghua Yi Xue Za Zhi; 2021 Jun; 101(22):1631-1634. PubMed ID: 34126710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
    Muchtar E; Dispenzieri A; Gertz MA; Kumar SK; Buadi FK; Leung N; Lacy MQ; Dingli D; Ailawadhi S; Bergsagel PL; Fonseca R; Hayman SR; Kapoor P; Grogan M; Abou Ezzeddine OF; Rosenthal JL; Mauermann M; Siddiqui M; Gonsalves WI; Kourelis TV; Larsen JT; Reeder CB; Warsame R; Go RS; Murray DL; McPhail ED; Dasari S; Jevremovic D; Kyle RA; Lin Y; Lust JA; Russell SJ; Hwa YL; Fonder AL; Hobbs MA; Rajkumar SV; Roy V; Sher T
    Mayo Clin Proc; 2021 Jun; 96(6):1546-1577. PubMed ID: 34088417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [AL Amyloidosis].
    Ueda M
    Brain Nerve; 2024 May; 76(5):583-587. PubMed ID: 38741500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [AL amyloidosis, from diagnosis to treatment].
    Villesuzanne C; Jaccard A; Nicol M
    Rev Prat; 2020 Dec; 70(10):1137-1141. PubMed ID: 33739663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When to Suspect a Diagnosis of Amyloidosis.
    Vaxman I; Gertz M
    Acta Haematol; 2020; 143(4):304-311. PubMed ID: 32340017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How I Approach Light Chain Amyloidosis.
    Chowdhury RB; Leung N
    G Ital Nefrol; 2023 Oct; 40(Suppl 81):. PubMed ID: 38007836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized Approach to Management of Light Chain Amyloidosis.
    Palladini G; Milani P
    J Natl Compr Canc Netw; 2023 Jan; 21(1):91-98. PubMed ID: 36634608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside.
    Basset M; Nuvolone M; Palladini G; Merlini G
    Expert Rev Hematol; 2020 Sep; 13(9):1003-1015. PubMed ID: 32721177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid Organ Transplantation in Amyloidosis.
    Theodorakakou F; Fotiou D; Dimopoulos MA; Kastritis E
    Acta Haematol; 2020; 143(4):352-364. PubMed ID: 32535598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid consults do not have to be vexing.
    D'Souza A
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):407-412. PubMed ID: 38066929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the elderly patient with AL amyloidosis.
    Nuvolone M; Milani P; Palladini G; Merlini G
    Eur J Intern Med; 2018 Dec; 58():48-56. PubMed ID: 29801808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic amyloidosis: moving into the spotlight.
    Cohen OC; Wechalekar AD
    Leukemia; 2020 May; 34(5):1215-1228. PubMed ID: 32269317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloidosis in Heart Failure.
    Ihne S; Morbach C; Obici L; Palladini G; Störk S
    Curr Heart Fail Rep; 2019 Dec; 16(6):285-303. PubMed ID: 31782077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group.
    Maurer MS; Dunnmon P; Fontana M; Quarta CC; Prasad K; Witteles RM; Rapezzi C; Signorovitch J; Lousada I; Merlini G
    Circ Heart Fail; 2022 Jun; 15(6):e009038. PubMed ID: 35331001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AL amyloidosis: untangling new therapies.
    Bal S; Landau H
    Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):682-688. PubMed ID: 34889374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin light chain amyloidosis: 2022 update on diagnosis, prognosis, and treatment.
    Gertz MA
    Am J Hematol; 2022 Jun; 97(6):818-829. PubMed ID: 35429180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future Developments in Light Chain Amyloidosis Management.
    Rodriguez M; Lenihan D; Merlini G
    Am J Med; 2022 Apr; 135 Suppl 1():S53-S57. PubMed ID: 35081388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloidosis of the Heart and Kidney.
    Adrogue HE
    Methodist Debakey Cardiovasc J; 2022; 18(4):27-33. PubMed ID: 36132587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment patterns and outcomes in light chain amyloidosis: An institutional registry of amyloidosis report in Argentina.
    Posadas-Martinez ML; Aguirre MA; Brulc E; Saez MS; Sorroche P; Machnicki G; Fernandez M; Nucifora EM
    PLoS One; 2022; 17(10):e0274578. PubMed ID: 36301970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.